Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prognostic biomarkers in HCV cirrhosis

MRI of the liverIn 2015, in close collaboration with HCV Research UK, STOP-HCV established the STOP-HCV Cirrhosis Study - a longitudinal study of patients with severe liver disease.

The cohort consists of 1264 patients recruited from 31 hospital sites across the UK. Each year data and samples are collected from these patients with the aim of identifying biomarkers which identify those patients most at risk of liver disease progression and/or development of liver cancer.